Embecta Corp. (EMBC) Stock Forecast
Data as of Jun 16, 2026Healthcare · Current price $3.06 (-2.56%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| May 23, 2025 | Marie Thibault | BTIG | $25.00 | +718.3% |
| Dec 2, 2024 | Kallum Titchmarsh | Morgan Stanley | $20.00 | +554.7% |
| Nov 27, 2024 | Marie Thibault | BTIG | $26.00 | +751.1% |
| Jul 15, 2024 | Kallum Titchmarsh | Morgan Stanley | $12.00 | +292.8% |
Top Analysts Covering EMBC
EMBC vs Sector & Market
| Metric | EMBC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.00 | 2.24 | 2.41 |
| Analyst Count | 5 | 8 | 19 |
| Target Upside | +61.5% | +11475.0% | +17.1% |
| P/E Ratio | 1.63 | 4.02 | 31.98 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $283M | $284M | $285M | 4 |
| 2026-09-30 | $1.07B | $1.07B | $1.07B | 3 |
| 2026-12-31 | $260M | $261M | $262M | 3 |
| 2027-03-31 | $259M | $260M | $261M | 3 |
| 2027-06-30 | $273M | $274M | $275M | 2 |
| 2027-09-30 | $275M | $276M | $278M | 2 |
| 2027-12-31 | $261M | $262M | $263M | 3 |
| 2028-03-31 | $258M | $258M | $260M | 2 |
| 2028-06-30 | $275M | $276M | $277M | 1 |
| 2028-09-30 | $279M | $280M | $281M | 1 |
| 2029-09-30 | $965M | $967M | $969M | 1 |
| 2030-09-30 | $938M | $941M | $943M | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.81 | $0.82 | $0.82 | 4 |
| 2026-09-30 | $2.81 | $2.81 | $2.82 | 3 |
| 2026-12-31 | $0.68 | $0.69 | $0.69 | 2 |
| 2027-03-31 | $0.67 | $0.68 | $0.68 | 2 |
| 2027-06-30 | $0.75 | $0.76 | $0.76 | 1 |
| 2027-09-30 | $0.79 | $0.79 | $0.79 | 1 |
| 2027-12-31 | $0.72 | $0.73 | $0.73 | 2 |
| 2028-03-31 | $0.71 | $0.71 | $0.72 | 3 |
| 2028-06-30 | $0.81 | $0.81 | $0.81 | 2 |
| 2028-09-30 | $0.86 | $0.87 | $0.87 | 2 |
| 2029-09-30 | $2.95 | $2.96 | $2.97 | 1 |
| 2030-09-30 | $3.05 | $3.06 | $3.07 | 1 |
Frequently Asked Questions
What is the analyst consensus for EMBC?
The consensus among 5 analysts covering Embecta Corp. (EMBC) is Hold with an average price target of $5.00.
What is the highest price target for EMBC?
The highest price target for EMBC is $26.00, set by Marie Thibault at BTIG on 2024-11-27.
What is the lowest price target for EMBC?
The lowest price target for EMBC is $12.00, set by Kallum Titchmarsh at Morgan Stanley on 2024-07-15.
How many analysts cover EMBC?
5 analysts have issued ratings for Embecta Corp. in the past 12 months.
Is EMBC a buy or sell right now?
Based on 5 analyst ratings, EMBC has a consensus rating of Hold (3.00/5) with a +61.5% upside to the consensus target of $5.00.
What are the earnings estimates for EMBC?
Analysts estimate EMBC will report EPS of $0.82 for the period ending 2026-06-30, with revenue estimated at $284M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.